Journal of Clinical Endocrinology & Metabolism, Vol 80, 200-205, Copyright © 1995 by Endocrine Society

ARTICLES

Prenatal diagnosis of congenital lipoid adrenal hyperplasia

P Saenger, Z Klonari, SM Black, N Compagnone, SH Mellon, A Fleischer, CA Abrams, CH Shackelton and WL Miller
Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York 10467.

Congenital lipoid adrenal hyperplasia (lipoid CAH) is a rare genetic disorder of adrenal and gonadal steroidogenesis of unknown cause in which cholesterol cannot be converted to pregnenolone. As a result, affected individuals can make no steroid hormones, so that all affected newborns are phenotypic females, irrespective of karyotype. We studied two pregnancies in a family with two previously affected children by examining fetal karyotype, genital ultrasonography, and amniotic fluid steroid concentrations and by performing ACTH tests on family members. Prenatal diagnosis correctly identified both an unaffected XX fetus and an affected XY fetus. In the affected pregnancy, amniotic fluid concentrations of progesterone and pregnenolone were 30% and 50% of normal, respectively, but concentrations of 17 alpha- hydroxypregnenolone, 17 alpha-hydroxyprogesterone, cortisol, dehydroepiandrosterone, androstenedione, and estriol were either extremely low or undetectable, suggesting that these detected steroids were donated by maternal steroidogenesis. Fetal cord blood obtained at the termination of pregnancy showed very low concentrations of estrogens donated by the mother's circulation. Absent fetal steroidogenesis was confirmed by gas chromatography and mass spectrometry of both fetal and maternal serum. The responses of 10 different steroids to adrenal stimulation with ACTH in the obligately heterozygous parents were normal. Thus, unlike the case with other forms of CAH, heterozygosity cannot be determined by hormonal responses to provocative testing with ACTH. Immunocytochemistry and Western blotting showed that the affected placental tissue contained P450scc protein, confirming that P450scc is intact in these patients.

This article has been cited by other articles:

				W. L. Miller StAR Search--What We Know about How the Steroidogenic Acute Regulatory Protein Mediates Mitochondrial Cholesterol Import Mol. Endocrinol., March 1, 2007; 21(3): 589 - 601. [Abstract] [Full Text] [PDF]

				X. Chen, B. Y. Baker, M. A. Abduljabbar, and W. L. Miller A Genetic Isolate of Congenital Lipoid Adrenal Hyperplasia with Atypical Clinical Findings J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 835 - 840. [Abstract] [Full Text] [PDF]

				I. P. Artemenko, D. Zhao, D. B. Hales, K. H. Hales, and C. R. Jefcoate Mitochondrial Processing of Newly Synthesized Steroidogenic Acute Regulatory Protein (StAR), but Not Total StAR, Mediates Cholesterol Transfer to Cytochrome P450 Side Chain Cleavage Enzyme in Adrenal Cells J. Biol. Chem., November 30, 2001; 276(49): 46583 - 46596. [Abstract] [Full Text] [PDF]

				T. Tajima, K. Fujieda, N. Kouda, J. Nakae, and W. L. Miller Heterozygous Mutation in the Cholesterol Side Chain Cleavage Enzyme (P450scc) Gene in a Patient with 46,XY Sex Reversal and Adrenal Insufficiency J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3820 - 3825. [Abstract] [Full Text] [PDF]

				H. S. Bose, S. Sato, J. Aisenberg, S. A. Shalev, N. Matsuo, and W. L. Miller Mutations in the Steroidogenic Acute Regulatory Protein (StAR) in Six Patients with Congenital Lipoid Adrenal Hyperplasia J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3636 - 3639. [Abstract] [Full Text]

				H. S. Bose, R. M. Whittal, M. A. Baldwin, and W. L. Miller The active form of the steroidogenic acute regulatory protein, StAR, appears to be a molten globule PNAS, June 22, 1999; 96(13): 7250 - 7255. [Abstract] [Full Text] [PDF]

				E. Korsch, M. Peter, O. Hiort, W. G. Sippell, B. M. Ure, B. P. Hauffa, and M. Bergmann Gonadal Histology with Testicular Carcinoma in Situ in a 15-Year-Old 46,XY Female Patient with a Premature Termination in the Steroidogenic Acute Regulatory Protein Causing Congenital Lipoid Adrenal Hyperplasia J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1628 - 1632. [Abstract] [Full Text]

				W. L. Miller Why Nobody Has P450scc (20,22 Desmoslase) Deficiencyg J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1399 - 1400. [Full Text]

				N. Ariyoshi, Y.-C. Kim, I. Artemenko, K. K. Bhattacharyya, and C. R. Jefcoate Characterization of the Rat Star Gene That Encodes the Predominant 3.5-Kilobase Pair mRNA. ACTH STIMULATION OF ADRENAL STEROIDS IN VIVO PRECEDES ELEVATION OF Star mRNA AND PROTEIN J. Biol. Chem., March 27, 1998; 273(13): 7610 - 7619. [Abstract] [Full Text] [PDF]

				E. Okuyama, N. Nishi, S. Onishi, S. Itoh, Y. Ishii, H. Miyanaka, K. Fujita, and Y. Ichikawa A Novel Splicing Junction Mutation in the Gene for the Steroidogenic Acute Regulatory Protein Causes Congenital Lipoid Adrenal Hyperplasia J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2337 - 2342. [Abstract] [Full Text] [PDF]

				H. S. Bose, O. H. Pescovitz, and W. L. Miller Spontaneous Feminization in a 46,XX Female Patient with Congenital Lipoid Adrenal Hyperplasia Due to a Homozygous Frameshift Mutation in the Steroidogenic Acute Regulatory Protein J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1511 - 1515. [Abstract] [Full Text] [PDF]

				H. S. Bose, T. Sugawara, J. F. Strauss, W. L. Miller, and The International Congenital Lipoid Adrenal Hyperp The Pathophysiology and Genetics of Congenital Lipoid Adrenal Hyperplasia N. Engl. J. Med., December 19, 1996; 335(25): 1870 - 1879. [Abstract] [Full Text] [PDF]

				D Lin, T Sugawara, J. Strauss 3rd, B. Clark, D. Stocco, P Saenger, A Rogol, and W. Miller Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis Science, March 24, 1995; 267(5205): 1828 - 1831. [Abstract] [PDF]